Skip to content

DCM Shriram Fine Chemicals Limited (DSFCL)

Small Cap

Industrials stocks · Small cap · NSE

DCM Shriram Fine Chemicals Limited operates in Specialty Chemicals, within the Industrials sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers.

₹25.65
-0.86 · -3.24%
Market cap ₹243 Cr
Data qualityFresh enough for analysisQuote updated 21 Oct, 03:31 pm IST
Details
Quote21 Oct, 03:31 pm IST
Base fundamentals06 Oct 2026 · screener
Latest result18 Aug, 01:03 am IST
Score21 Oct, 04:30 am IST · v4.3-runtime-valuation
Tags02 May 2026
Coverage12/14 · 86%
Valuation2026-07-20 · Rf 6.8% · Industrials P/E 26.2 (n=537)
Technical timing lens

Trend score and candlestick chart

49Neutral

SMA20 +9.2% / mo · MACD −

Stock trend: 51
Sector RS: 46
Sector 3M: -7.1% vs Nifty 500 -5.6%

Latest mapped FPI equity flow was not positive. View sector evidence

Technical chart

DSFCLD candles · FIT view+2.5%
Latest close ₹25.65 on 2026-10-21

Daily history is available from 2026-02-17; the requested 1Y window is partially covered.

Bar
-2.3%
RSI
38
MACD hist
-0.41
52W pos
24%
Visible chart range
Candle interval
2026-10-21O ₹26.25H ₹26.85L ₹25.55C ₹25.65Vol 52,359 sh
₹21.63₹24.40₹27.17₹29.94₹32.71₹25.652026-032026-06VolRSIMACD2026-042026-062026-082026-092026-11
Up bar
Down bar
EMA 20
EMA 50
Volume + 20D avg
Result date
RSI(14)
MACD / signal
Market context

Relative performance and chart statistics

Adjusted completed-session prices, rebased to 100

DSFCLNifty India ManufacturingNifty 500
-11%-0%+10%+21%21 Jul2 Sept21 Oct21 Oct 2026DSFCL -4.2%Nifty India Manufactu… -7.7%Nifty 500 -6.5%
DSFCL
-4.2%
Nifty 500
-6.5%
Nifty India Manufacturing
-7.7%
Vs Nifty 500
+2.3 pp
Chart stats
21 Oct 2026
From 52W high
-51.1%
₹52.5
52W range position
24%
₹17.3 - ₹52.5
ATR (14)
5.6%
₹1.4
Volume vs 20D
0.76x
Latest completed session
Avg traded value
₹0.2 Cr
20-session average
20D price channel
₹25.6 - ₹32.2
47.8% annualized volatility
Research snapshot

What the evidence says now

Weak fundamentals, management evidence is still limited to a financial-only Trust Lite signal, price trend is neutral, and recent execution is weak.

Suggested next step
Check latest quarters
Result consistency is weak; verify whether the thesis is improving or deteriorating.
U-Score
Legacy · OVERVALUED
23

Fundamental lens: valuation, quality, growth, balance sheet, and cash flow.

Latest result
Bad
0

Revenue -8.0% · PAT -39.9% YoY

Technical
Neutral
49

Price trend and sector-relative-strength timing.

Valuation
Legacy model
—

Legacy margin-of-safety estimate; the revised evidence label remains in shadow validation.

Trust
Limited evidence
62

Financial-only signal; management claim evidence is not sufficient yet.

Financials

Fundamentals, quarterly history, margins, returns and balance-sheet evidence

Latest result

Quarter ended 30 Jun 2026

Bad · 0/100

Rev -8% YoY · PAT -40% YoY · margin compression

Filed 14 Aug 2026
Open results browser →
MetricThis quarterYoYQoQ
Revenue₹90.8 Cr-8.0%-2.5%
EBITDA₹5.1 Cr-30.3%+303.2%
Operating margin5.6%-180 bps+832 bps
PAT₹2.6 Cr-39.9%NDF
PAT margin2.9%-152 bps+696 bps

NDF means not disclosed in the current structured filing feed. It is intentionally not treated as zero.

Fundamentals

Valuation

P/E
—
P/B
1.15
EV/EBITDA
28.44
Market Cap
243.00Cr

Profitability

ROE
-0.29%
ROCE
0.74%
ROA
-1.69%
Dividend Y
1.43%

Growth (CAGR)

Revenue 5Y
-6.13%
EPS 5Y
—
Revenue 3Y
-6.13%
EPS 3Y
—

Balance Sheet

Debt/Equity
0.06
Interest Coverage
0.50×
Altman Z
4.21
Book Value
24.30

Cash Flow

FCF Yield
11.11%
FCF Positive Y
2/5
OCF
16.00 Cr
EPS TTM
-0.56

Shareholding

Promoter Hold
50.11%
Promoter Pledge
0.00%
Momentum 52W
30%

Financial History

Updated 21/10/2026

Revenue

₹ Cr
Latest: 90.8-2.5% vs prev
0113.1Dec 2024: 93.3Mar 2025: 113Jun 2025: 98.6Sep 2025: 96.9Dec 2025: 97.0Mar 2026: 93.1Jun 2026: 90.8Q3 24FY25Q1 25Q2 25Q3 25FY26Q1 26

Net Profit

₹ Cr
Latest: 2.6+167.6% vs prev
-3.804.4Dec 2024: 2.4Mar 2025: 4.4Jun 2025: 4.3Sep 2025: -2.5Dec 2025: -1.5Mar 2026: -3.8Jun 2026: 2.6Q3 24FY25Q1 25Q2 25Q3 25FY26Q1 26
ROE is shown only in the Annual view — quarterly equity data isn't published.

Technicals

Trend interpretation, Stage 2, relative strength, volume and indicator evidence

Daily technical trend read

Mixed signals

Signals are conflicting — long-term trend unclear. RSI 38. Wait for confirmation.

  • SMA20 rising (~8.4% over last month) — short-term momentum positive.
  • RSI(14) at 38 — falling, no extreme reading.
  • MACD below signal, histogram expanding negatively — bearish momentum building.
  • 51% off 52W high · 48% above 52W low.

Mechanical read from the price + indicator series above. Not a recommendation — technical setups can reverse without warning, especially around earnings and macro events.

Nifty 500 leadership

Relative Strength & Trend Stage

68
RS percentile
Stage 1 Base / Transition
1M return
-6.5%
3M return
-4.2%
6M return
+4.3%
1Y return
-
RS 1D
-2
RS 20D
-10
Sector rank
#2
Industry rank
#6
Stage evidence
  • Price is within 0.9% of the 30-week proxy.
  • The 30-week proxy changed -0.0% over 20 sessions.
  • The moving-average structure does not confirm Stage 2 or Stage 4.
50-DMA
price below
200-DMA
unavailable
Sector
leading
Industry
leading
Partial-history RS: the 3M and 6M weights are re-normalised because 12M history is unavailable.
Relative-strength line vs Nifty 500 (base 100)
167 observations
21 Oct 2026Value 58.21-2.33%
39557187103Feb 26May 26Jul 26Oct 2658
RS vs Nifty 50058

Valuation & peers

U-Score 23 · legacy U-Score band OVERVALUED · valuation evidence and comparable companies

23U-SCORE
OVERVALUED

Fundamental score breakdown

U band · OVERVALUED
Valuation5/30
Growth2/25
Quality0/20
Balance Sheet10/15
Cash Flow8/10
Piotroski
3/9 (+1)
Penalties
-3
Raw sum
23

Why this score?

Top U-Score contributors and drags from the latest stored fundamentals.

23/100 · legacy band OVERVALUED

Positive drivers

  • FCF yield is supportive at 11.1%.
  • Cash flow contributes 8/10 to the score.
  • Balance sheet contributes 10/15 to the score.

Main drags

  • Penalty bucket subtracts 3 points.
  • Quality is weaker at 0/20; verify the latest quarterly trend.
  • Growth is weaker at 2/25; verify the latest quarterly trend.
Sector valuation model

Cyclical valuation: normalized earnings, not just trailing PE

Cyclical companies can look cheapest near peak profits, so IndiaPulse flags value-trap risk separately.

Cyclical normalized
Primary lens
Mid-cycle PE/EV/EBITDA using multi-year average margins or earnings.
Secondary checks
Current margin versus 5-year average, balance sheet strength, commodity cycle.
Main risk check
A low trailing PE may mean peak-cycle earnings, not true cheapness.
PE
—
PB
1.1
EV/EBITDA
28.4
ROE
-0.3%
ROCE
0.7%
FCF Yield
11.1%
Debt/Equity
0.1
MoS
—
Cyclical/value-trap warning
This sector can look cheap when profits are temporarily high. Check mid-cycle margins/earnings before relying on trailing PE.
Score movement

Stored run vs live recompute

This shows the stored score trend when snapshots exist, and also compares the latest stored nightly score with a live recompute from current fundamentals and price.

Stored run: 21 Oct 2026
v4.3-runtime-valuation
Final score
23
Previous: 23
Legacy U-Score band
OVERVALUED
Previous: OVERVALUED
Margin of safety
—
No stored baseline yet

Score history

12 stored score snapshots. Latest stored move: +0 points.

21 Oct 2026
v4.3-runtime-valuation
23
23
23
23
23
23
23
23
23
23
23
23

Factor attribution

No pillar movement versus the latest stored run. Historical score trend will appear after snapshot storage is enabled.

Modelled fair value

Graham Number
—
Growth-justified P/E
7.4
Growth-justified Value
—
— MoS
PEG
—

Comparable companies

Peers

Business-comparable peers in Industrials — ranked by industry, sub-sector, theme-tag overlap, market cap, and U-Score similarity. Green cells mark the best available peer metric in this table.

Compare all ↗
Ticker
Name
Why peer
Score
PE
ROE
MoS
Verdict
CHEMBOND
Small
Chembond Material Technologies Limited
Specialty Chemicals
match 167
28
15.8
8.8%
-285%
OVERVALUED
DIAMINESQ
Small
Diamines & Chemicals Limited
Specialty Chemicals
match 167
17
—
-7.9%
—
OVERVALUED
KANCHI
Small
Kanchi Karpooram Limited
Specialty Chemicals
match 164
16
21.5
2.4%
-733%
OVERVALUED
HINDCON
Small
Hindcon Chemicals Limited
Specialty Chemicals
match 164
10
37.5
5.5%
-620%
OVERVALUED
DAICHI
Small
Dai-Ichi Karkaria Limited
Specialty Chemicals
match 163
28
101.0
-0.3%
-163%
OVERVALUED

Business, management & trust

Growth engines, risks, management commitments and evidence-backed delivery

Business and thesis

Issuer presentation review pending

DCM Shriram Fine Chemicals Limited operates in Specialty Chemicals, within the Industrials sector. Use the latest filing and company disclosures below to verify its revenue mix and current business drivers. The structured result feed currently covers the quarter ended 30 Jun 2026. Investor presentations and earnings-call PDFs will be added as issuer-backed evidence before management claims appear here.

Trust Score
62Limited evidence · low confidenceTrust Lite

Trust asks: does management behaviour match later outcomes? Higher is better, but confidence and evidence depth matter as much as the number.

Limited evidence: Claim history is still being built. It ranks around the 35th percentile of the scored universe and 32nd percentile within Industrials. Main check: financial discipline is weak at 32/100.

This is a financial-behaviour screen, not a claim-tested management reliability verdict.

Computed 05 Sept 2026
management-trust-v1
10 docs text-extracted · 0 concalls text-extracted
Score band
Limited evidence

Financial behaviour is scored, but management claims do not yet have enough outcome checks.

Relative rank
35th percentile

overall median 67 · Industrials: 32nd pctile, median 68 · Small: 40th pctile, median 66

Evidence depth
Financial-only

10 documents have extracted text, but claim history is not strong enough yet.

Claim delivery
Outcome history still building

0 claims extracted · No contradicted claim yet

How to read this Trust Score

Limited evidence · low confidence
What it measures
Reliability of management and financial delivery, using financial behaviour only.
Confidence
Treat this as an early read until more concalls and outcomes are matched.
Investor use
Acceptable, but check the weakest sub-score before increasing exposure.

Read Trust alongside U-Score, result consistency, and technical trend. A cheap stock with weak Trust needs a larger margin of safety; a high Trust score does not make an expensive stock attractive by itself.

Forensic breakdown

Read low sub-scores as due-diligence warnings, not automatic sell signals.

Promoter
78
strong · holding, pledge, alignment
Cash flow
77
strong · profit to cash conversion
Balance sheet
74
acceptable · leverage and solvency
Discipline
32
weak · capital discipline
Results
41
weak · quarterly consistency

Trust positives

  • ▸Promoter pledge is zero.
  • ▸FCF yield is 12%.
  • ▸Debt/equity is 0.06.

Trust risks

  • ▸3 latest quarters had PAT decline worse than 25% YoY.
  • ▸Interest coverage is 0.5x.
  • ▸ROCE is low at 0.7%.
  • ▸ROE is low at -0.3%.

Trust Lite uses financial behaviour only. Prefer claim-tested Trust when enough concall claims have later outcomes.

Important announcements & filings

Latest exchange and company disclosures found within the past two years.

12 shown
AnnouncementSep 2026

Sep 2026 · Announcement under Regulation 30 (LODR)-Change in Directorate 25 Sep - Mr. Rohit Bhandari resigned as Independent Director effective September 24, 2026.

Source: Bse

Open source ↗
AnnouncementSep 2026

Sep 2026 · Announcement under Regulation 30 (LODR)-Change in Management 25 Sep - Mr. Rohit Bhandari resigned as Independent Director effective September 24, 2026.

Source: Bse

Open source ↗
AnnouncementSep 2026

Sep 2026 · Announcement under Regulation 30 (LODR)-Change in Directorate 17 Sep - Mr. Vijay Anand resigned as Independent Director effective September 17, 2026.

Source: Bse

Open source ↗
AnnouncementSep 2026

Sep 2026 · Announcement under Regulation 30 (LODR)-Change in Management 17 Sep - Mr. Vijay Anand resigned as Independent Director effective September 17, 2026, citing professional commitments.

Source: Bse

Open source ↗
AnnouncementSep 2026

Sep 2026 · Announcement under Regulation 30 (LODR)-Change in Directorate 9 Sep - Independent Director Venkata Rama Subbu Behara resigned effective September 8, 2026.

Source: Bse

Open source ↗
AnnouncementSep 2026

Sep 2026 · Announcement under Regulation 30 (LODR)-Change in Management 9 Sep - Independent director Venkata Rama Subbu Behara resigned effective September 8, 2026.

Source: Bse

Open source ↗
AnnouncementSep 2026

Sep 2026 · Announcement under Regulation 30 (LODR)-Change in Directorate 3 Sep - Anil Kumar Khaitan appointed Additional Non-Executive Independent Director for 5 years from September 4, 2026, subject to approval.

Source: Bse

Open source ↗
Announcement

Announcement under Regulation 30 (LODR)-Newspaper Publication 10 Sep - Copy of Newspaper publication for Postal Ballot

Source: Bse

Open source ↗
AnnouncementAug 2026

Aug 2026 · Announcement under Regulation 30 (LODR)-Change in Management 18 Aug - Mr. Siddhartha Mukherjee resigned as Independent Director effective 15 August 2026 due to personal commitments.

Source: Bse

Open source ↗
AnnouncementAug 2026

Aug 2026 · Announcement under Regulation 30 (LODR)-Change in Directorate 14 Aug - Q1 FY2026 results approved; Akshay Dhar resigns, Rudra Shriram appointed MD from 15 August 2026.

Source: Bse

Open source ↗
AnnouncementAug 2026

Aug 2026 · Announcement under Regulation 30 (LODR)-Change in Directorate 18 Aug - Siddhartha Mukherjee resigned as Independent Director effective 15 August 2026 due to personal commitments.

Source: Bse

Open source ↗
AnnouncementAug 2026

Aug 2026 · Announcement under Regulation 30 (LODR)-Change in Directorate 14 Aug - Board approved Q1 FY27 results on 14 Aug 2026; Akshay Dhar resigned, Rudra Shriram appointed MD.

Source: Bse

Open source ↗
Verify on:NSE India ↗
All information is for study purposes only. For investment decisions, consult your financial advisor. See Playbook for methodology.